Jackob Moskovitz

Jackob Moskovitz

Mar 21, 2019

Group 6 Copy 153
-1
    Please wait...

    About This Project

    Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Are current antibacterial treatments resulting in the evolution of more virulent multidrug resistant bacteria?

    Each year in the U.S. 23,000 people die as a direct result of antibiotic resistant infections. I hypothesize...

    Making Inexpensive Insulin Using Microalgae

    This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae before...

    Can we noninvasively measure blood sugar for diabetes?

    Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

    Campaign Ended

    A medicine project funded by 45 people